On December 8, SK chemicals (CEO, Chang-Geun Kim) announced that it had started selling a new orally soluble film-type male impotence medication, Embix S 50mg, (Mirodenafil Oral Disintegrating Film 50mg), the first such medication in the world.
The Company said that the new version of Embix is a new and innovative orally soluble film-type of medication that is sufficiently thin and light in weight to be carried in a wallet.
The new Embix S can be taken without water. The new medication had its area under the plasma level-time curve (AUC), which means the medication absorption level, improved by more than 30% compared to existing products, using the company’s technology.
Embix S is priced at 5,000 won per tablet, a highly competitive price that has been set to make it available to a wider number of people.
Commenting on the medication, Mr. Choi Nakjong, head of the marketing team at the Life Science Biz of SK chemicals, said, “In future, the development of new medications will be focused on the exploration of invisible needs, as is the case with Embix S. The new medication will help us post sales amounting to more than 30 billion won in 2012 based on the differentiated product quality and reasonable price.”
According to IMS Data, the size of the market for orally administered male impotence medication is estimated to have exceeded 100 million won in 2011, posting a near 10% growth rate since 2008.
SK chemicals is preparing diverse new medications, using high-end technology obtained through Trast (an arthritis skin patch) and Omed (a duodenal ulcer medication) among others, and is making efforts to expand the scope of research and application of medication production.
Embix S is simply administered by allowing it (50mg ~ 100mg once a day) to melt in the mouth one hour prior to sexual relations. Each packet contains ten pills.
The figure 8 (the new medication went on sale on December 8) symbolizes the restoration of paradise, resuscitation or rebirth, or magical power in ancient West Asia and good fortune in China, where the medication has been introduced.